These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11341669)

  • 1. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
    See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
    Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
    Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
    Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophrenia.
    Meskanen K; Ekelund H; Laitinen J; Neuvonen PJ; Haukka J; Panula P; Ekelund J
    J Clin Psychopharmacol; 2013 Aug; 33(4):472-8. PubMed ID: 23764683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
    Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial.
    Amini M; Ghamar Chehreh ME; Khedmat H; Valizadegan G; Babaei M; Darvishi A; Taheri S
    J Egypt Public Health Assoc; 2012 Apr; 87(1-2):29-33. PubMed ID: 22415333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
    James LP; Kearns GL
    Clin Pharmacokinet; 1996 Aug; 31(2):103-10. PubMed ID: 8853932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
    Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
    Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FAMOTIDINE VERSUS PLACEBO IN NON ULCER DYSPEPSIA TREATMENT].
    Cahuayme L; Berríos J; Recavarren S; Huerta Mercado J; Bussalleu A
    Rev Gastroenterol Peru; 2000; 20(3):213-228. PubMed ID: 12140583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
    Kinoshita Y; Chiba T;
    J Gastroenterol; 2012 Apr; 47(4):377-86. PubMed ID: 22183857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
    Huertas-Ceballos A; Logan S; Bennett C; Macarthur C
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003017. PubMed ID: 18254013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
    Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
    J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.